Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia

References

• Abrass CK. 2004. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol. 24:46–53. doi:10.1159/000075925. PMID:14707435.
   PubMed Web of Science ®Google Scholar
• Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. 1974. Enzymatic determination of total serum cholesterol. Clin Chem. 20:470–475. PMID:4818200.
   PubMed Web of Science ®Google Scholar
• Anjaneyulu M, Chopra K. 2005. Diltiazem attenuates oxidative stress in diabetic rats. Ren Fail. 27:335–344.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2009. Diagnosis and classification of diabetes mellitus. Diabetes Care. 32:S62–S67. doi:10.2337/dc09-S062. PMID:19118289.
   PubMed Web of Science ®Google Scholar
• Arora MK, Singh UK. 2013. Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update. Vascul Pharmacol. 58:259–271. doi:10.1016/j.vph.2013.01.001. PMID:23313806.
   PubMed Web of Science ®Google Scholar
• Arora MK, Singh UK. 2014. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. Curr Drug Targets. 15:531–538. doi:10.2174/1389450115666140321120635. PMID:24655140.
   PubMed Web of Science ®Google Scholar
• Arora MK, Singh UK, Bansal R. 2014. Morphological effect of combination of fenofibrate and saxagliptin on kidney of diabetic rats. Int J Pharmcy Pharm Sci. 6:483–487.
   Google Scholar
• Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M. 2009a. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol Res. 60:24–32. doi:10.1016/j.phrs.2009.02.002.
   PubMed Web of Science ®Google Scholar
• Balakumar P, Arora MK, Singh M. 2009b. Emerging role of PPAR ligands in the management of diabetic nephropathy. Pharmacol Res. 60:170–173. doi:10.1016/j.phrs.2009.01.010.
   PubMed Web of Science ®Google Scholar
• Bonsnes RW, Taussky HA. 1945. On the colorimetric determination of creatinine by the Jaffe reaction. J biol Chem. 158:581–591.
   Web of Science ®Google Scholar
• Bucolo G, David H. 1973. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 19:476–482. PMID:4703655.
   PubMed Web of Science ®Google Scholar
• Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH. 2004. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol. 183:183–194. doi:10.1677/joe.1.05647. PMID:15525586.
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Mukherjee A, Nandy S. 2012. Protective effects of the aqueous leaf extract of Aloe barbadensis on gentamicin and cisplatin-induced nephrotoxic rats. Asian Pacific J Trop Biomed. 2:1754–1763. doi:10.1016/S2221-1691(12)60490-0.
   Google Scholar
• Connolly SB, Sadlier D, Kieran NE, Doran P, Brady HR. 2003. Transcriptome profiling and the pathogenesis of diabetic complications. J Am Soc Nephrol. 14:279–283. doi:10.1097/01.ASN.0000078022.77369.EB.
   Web of Science ®Google Scholar
• Dounousi E, Duni A, Leivaditis K, Vaios V, Eleftheriadis T, Liakopoulos V. 2015. Improvements in the management of diabetic nephropathy. Rev Diabet Stud. 12:119–133. doi:10.1900/RDS.2015.12.119. PMID:26676665.
   PubMedGoogle Scholar
• Duvillard L, Florentin E, Lizard G, Petit JM, Galland F, Monier S, Gambert P, Verges B. 2003. Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Diabetes Care. 26:1540–1544.
   PubMed Web of Science ®Google Scholar
• Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R. 2003. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 42:617–622. doi:10.1016/S0272-6386(03)00826-6. PMID:14520612.
   PubMed Web of Science ®Google Scholar
• Ellman GL. 1959. Tissue Sulfhydryl groups. Archives Biochem Biophy. 82:70–77. doi:10.1016/0003-9861(59)90090-6.
   PubMed Web of Science ®Google Scholar
• Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Seron D. 2015. Renal Biopsy in Type 2 Diabetic Patients. J Clin Med. 4:998–1009. doi:10.3390/jcm4050998. PMID:26239461.
   PubMed Web of Science ®Google Scholar
• Fawcett JK, Scott JE. 1960. A rapid and precise method for the determination of urea. J Clin Pathol. 13:156–159. doi:10.1136/jcp.13.2.156. PMID:13821779.
   PubMed Web of Science ®Google Scholar
• Figarola JL, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S. 2008. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia. 51:882–891. doi:10.1007/s00125-008-0935-x. PMID:18317729.
   PubMed Web of Science ®Google Scholar
• Finco DR, Duncan JR. 1976. Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature. J Am Vet Med Assoc. 168:593–601. PMID:1270342.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Mauer M. 2007. Histopathology of diabetic nephropathy. Semin Nephrol. 27:195–207. doi:10.1016/j.semnephrol.2007.01.012. PMID:17418688.
   PubMed Web of Science ®Google Scholar
• Fowler MJ. 2008. Microvascular and macrovascular complications of diabetes. Clin Diab. 26:77–82.
   Google Scholar
• Giunti S, Barit D, Cooper ME. 2006. Mechanisms of diabetic nephropathy: role of hypertension. Hypertension. 48:519–526. doi:10.1161/01.HYP.0000240331.32352.0c. PMID:16952978.
   PubMed Web of Science ®Google Scholar
• Halimi S, Verges B. 2014. Adverse effects and safety of SGLT-2 inhibitors. Diabetes Metab. 40:28–34. doi:10.1016/S1262-3636(14)72693-X.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yu L, Border WA, Noble NA. 2003. TGF-beta isoforms in renal fibrogenesis. Kidney Int. 64:844–856. doi:10.1046/j.1523-1755.2003.00162.x. PMID:12911534.
   PubMed Web of Science ®Google Scholar
• Huang YH, Wang HT, Zhu QZ, Zhang H, Shen W, Wang Y. 2004. Combination therapy with losartan and fosinopril for early diabetic nephropathy. Di Yi Jun Yi Da Xue Xue Bao. 23:963–965.
   Google Scholar
• Inoki K, Haneda M, Ishida T, Mori H, Maeda S, Koya D, Sugimoto T, Kikkawa R. 2000. Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells. Kidney Int Suppl. 77:76–80. doi:10.1046/j.1523-1755.2000.07712.x.
   Google Scholar
• Jangra A, Datusalia AK, Sharma SS. 2014. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. Neurol Res. 36:619–626. doi:10.1179/1743132813Y.0000000301. PMID:24620961.
   PubMed Web of Science ®Google Scholar
• Jeong SI, Kim KJ, Choo YK, Keum KS, Choi BK, Jung KY. 2004. Phytolacca americana inhibits the high glucose-induced mesangial proliferation via suppressing extracellular matrix accumulation and TGF-beta production. Phytomedicine. 11:175–181. doi:10.1078/0944-7113-00291. PMID:15070169.
   PubMed Web of Science ®Google Scholar
• Johnson SA, Spurney RF. 2015. Twenty years after ACEIs and ARBs: Emerging treatment strategies for diabetic nephropathy. Am J Physiol Renal Physiol. 309:F807–F820. doi:10.1152/ajprenal.00266.2015. PMID:26336162.
   PubMed Web of Science ®Google Scholar
• Joladarashi D, Salimath PV, Chilkunda ND. 2011. Diabetes results in structural alteration of chondroitin sulfate/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components. Glycobiology. 21:960–972. doi:10.1093/glycob/cwr029. PMID:21406563.
   PubMed Web of Science ®Google Scholar
• Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. 1997. Antioxidant defence system in diabetic kidney: a time course study. Life Sci. 60:667–679. doi:10.1016/S0024-3205(96)00702-3. PMID:9048969.
   PubMed Web of Science ®Google Scholar
• Kedar P, Chakrabarti CH. 1982. Effects of bittergourd (Momordica charantia) seed & glibenclamide in streptozotocin induced diabetes mellitus. Indian J Exp Biol. 20:232–235. PMID:6811427.
   PubMed Web of Science ®Google Scholar
• Kolset SO, Reinholt FP, Jenssen T. 2012. Diabetic nephropathy and extracellular matrix. J Histochem Cytochem. 60:976–986. doi:10.1369/0022155412465073. PMID:23103723.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275. PMID:14907713.
   PubMed Web of Science ®Google Scholar
• Lyman JL. 1986. Blood urea nitrogen and creatinine. Emerg Med Clin North Am. 4:223–233. PMID:3516645.
   PubMedGoogle Scholar
• Mangrum AJ, Bakris GL. 2004. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues. Semin Nephrol. 24:168–175. doi:10.1016/j.semnephrol.2003.11.001. PMID:15017529.
   PubMed Web of Science ®Google Scholar
• Mohamed EAK. 2011. Antidiabetic Antihypercholestermic and Antioxidative Effect of Aloe vera Gel Extract in Alloxan Induced Diabetic Rats Aus. J Basic and App Sci. 5:1321–1327.
   Google Scholar
• Mohapatra S, Rath B, Maharana CS, Pradhan S, Tripathy S. 2013. Hypoglycemic hypolipidemic properties of Aloe vera in streptozotocin induced diabetic rats. Int J Biol Med Res. 4:2783–2787.
   Google Scholar
• Mude RN, Bandela V, Macha B. 2015. Regulation of diabetes and alterations in Antioxidant enzymes on supplementation of Aloe vera in male albino-rats. World J Pharmaceutical Res. 4:1401–1413.
   Google Scholar
• Najafian B, Kim Y, Crosson JT, Mauer M. 2003. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol. 14:908–917. doi:10.1097/01.ASN.0000057854.32413.81. PMID:12660325.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Annals of Biochemistry. 95:351–358. doi:10.1016/0003-2697(79)90738-3.
   Web of Science ®Google Scholar
• Park IS, Kiyomoto H, Abboud SL, Abboud HE. 1997. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes. 46:473–480. doi:10.2337/diab.46.3.473. PMID:9032105.
   PubMed Web of Science ®Google Scholar
• Phillips AO, Steadman R. 2001. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol. 17:247–252.
   Web of Science ®Google Scholar
• Ramachandraiahgari RMY, Somesula SR, Adi PJ, Mannur IS, Enamalaa M, Matcha B. 2012. Protective role of ethanolic extract of Aloe vera antioxidant properties on liver and kidney of streptozotocin-induced diabetic rats. Digest J Nanomaterials and Biostructures. 7:175–184.
   Web of Science ®Google Scholar
• Sahu PK, Giri DD, Singh R, Pandey P, Gupta S, Shrivastava AK, Kumar A, Pandey KD. 2013. Therapeutic and Medicinal Uses of Aloe vera: A Review. Pharmacol Pharmacy. 4:599–610. doi:10.4236/pp.2013.48086.
   Google Scholar
• Surjushe A, Vasani R, Saple DG. 2008. Aloe vera: A short review. Indian J Dermatol. 53:163–166. doi:10.4103/0019-5154.44785. PMID:19882025.
   PubMedGoogle Scholar
• Tomohiro T, Kumaib T, Satoa T, Takebab Y, Kobayashib S, Kimuraa K. 2007. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Life Sci. 80:1364–1372. doi:10.1016/j.lfs.2006.11.054. PMID:17331548.
   PubMed Web of Science ®Google Scholar
• Trevisan R, Dodesini AR, Lepore G. 2006. Lipids and renal disease. J Am Soc Nephrol. 17:145–147. doi:10.1681/ASN.2005121320.
   PubMed Web of Science ®Google Scholar
• Trinder P. 1969. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 22:158–161. doi:10.1136/jcp.22.2.158. PMID:5776547.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Sato T, Liang K. 2003. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis. Kidney Int. 63:1756–1763. doi:10.1046/j.1523-1755.2003.00911.x. PMID:12675851.
   PubMed Web of Science ®Google Scholar
• Wang W, Koka V, Lan HY. 2005. Transforming growth factor-β and Smad signalling in kidney diseases. Nephrol. 10:48–56. doi:10.1111/j.1440-1797.2005.00334.x.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K. 1986. Urinary protein as measured with a pyrogallol red-molybdate complex manually and in a Hitachi 726 automated analyzer. Clin Chem. 32:1551–1554. PMID:3731450.
   PubMed Web of Science ®Google Scholar
• Yasin MS, Ferdosi MFH, Nasir F, Shahzad M, Malik A. 2011. Effect of Aloe vera gel on lipid profile in alloxan induced diabetic mice. Mycopath. 9:67–70.
   Google Scholar